Greg Studdard


Greg Studdard brings an expansive network of connections as well as commercial build and new technology launch experience to BioFluidica. He has successfully led several companies and sales teams with breakthrough technologies and services into new Standards of Care in Medicine during his decades long career. He was part of the then largest acquisition in diagnostics in the world when Verinata Health was acquired by Illumina in 2013.

Greg received double majors in Marketing and Management with a minor in Psychology at the University of Virginia and later received his MBA from Chadwick University, a UAB program. He launched national testing at the first prenatal screening lab in the country early in his career with NTD Labs (a Perkin-Elmer/Revvity and later Eurofins company). Later he brought new technology advances in screening and genetic testing to market at GeneCare (Alere at acquisition and now Optum). He brings management, sales, partnering, marketing and managed care experience from his varied experiences, which includes running an Ultrasound company as well as being CCO at a Diabetes company.